Search




Research outputs

Analysis of factors with impact on duration of hospitalisation for patients operated for breast cancer during COVID 19 pandemic   [2022]

Maksimovic, Z; Curcic, A; Ljubisavljevic, R; Zarev, I; Simovic, I; Misic, M; Mitrovic, S; Mihajlovic, Z; Bursac, S; Vukasinovic, J;
Kosic, D; Maljevac, E; Bihorac, Dzemil; Vatricevic, S; Babic, Z; Rsovac, N; Azanjac, A; Aleksandrovic, D; Tanasijevic, Jasminka B; Kostic, N;

Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America   [2016]

Karalexi, Maria A; ...; Zivkovic, Snezana V; ...; (broj, koautora 24)

A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study   [2013]

Nabors, Louis Burt; Fink, Karen L; Mikkelsen, Tom; Grujicic, Danica M; Tarnawski, Rafal; Nam, Do-Hyun; Perry, James R; Mazurkiewicz, Maria; Picard, Martin; Reardon, David A

Increasing number of melanoma in situ in Serbia due to media campaign - experience of melanoma center   [2013]

Nikolić, Aleksandra  ; Nikolić, Dragan  ; Stanimirović V.; Gačić J.

Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)   [2013]

Zarić, Bojan  ; Fennell DA; Goss GD; Andric Zoran G; Bondarenko I; Ceric T; Poddubskaya E; Teofilovici F; Guo W; Ramalingam S

137 Antitumor activities of some macrofungi extracts   [2014]

Zizak, Z.  ; Klaus, Anita  ; Kozarski, Maja  ; Vunduk, Jovana  ; Nikšić, Miomir ; Juranić, Zorica  

XRCC1 Arg399Gln polymorphism and susceptibility for hereditary BRCA1/2 negative breast cancer in Serbian women   [2014]

Krivokuca, Ana M  ; Malisic, Emina J  ; Rakobradovic, Jelena D ; Jankovic, Radmila N  ; Brankovic-Magic, Mirjana V  

2854 Sentinel lymph node biopsy in medullary thyroid carcinomas - A pilot study   [2015]

Džodić, Radan ; Santrac, Nada; Goran, Merima  ; Djurisic, Igor  ; Buta, M.  ; Pupic, Gordana  ; Markovic, Ivan  

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial   [2023]

Holmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H;
Silovski Tajana; Šeparović Robert; Bashford Anna; Zotano Guerrero Angel; Dendeluri Neelima; Patt Debra; Gokmen Erhan; Gore Ira; Smith II John W; Loibl Sibylle; Masuda Norikazu; Tomašević Zorica  ; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group;

Filteri

Po tipu